Related Experiment Video
Updated: Jun 23, 2026
08:35
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Cholesterol Overload Drives Hepatic Steatosis by Inhibiting OGT-dependent PPARα O-GlcNAcylation and Transactivation
Rui Guo1,2, Yanhui Li1, Qinchao Ding2
1Department of Kinesiology and Nutrition, University of Illinois Chicago, Chicago, IL, USA.
International Journal of Biological Sciences
|June 22, 2026
Summary
Dietary cholesterol overload causes liver fat accumulation by suppressing fatty acid breakdown via a new cholesterol-OGT-PPARα pathway. Targeting this pathway may treat metabolic dysfunction-associated steatotic liver disease (MASLD).
Area of Science:
- Hepatology
- Metabolic Biochemistry
- Molecular Biology
Background:
- Dietary cholesterol exacerbates liver disease, but its role in hepatic steatosis (fatty liver) in MASLD and ALD is unclear.
- Hepatic steatosis is a key early feature of MASLD and ALD, driven by disrupted lipid metabolism.
Purpose of the Study:
- To investigate how cholesterol overload disrupts hepatic triacylglycerol metabolism and causes steatosis.
- To elucidate the molecular mechanisms linking cholesterol to fat accumulation in hepatocytes.
Main Methods:
- Used dietary and cellular cholesterol-loading models in hepatocytes and mice.
- Performed integrated transcriptomic, metabolomic, and biochemical analyses.
- Employed genetic (OGT knockout) and pharmacologic (WY14643) modulations to assess causality.
Main Results:
- Cholesterol overload induced dose-dependent, cell-autonomous hepatic fat accumulation by suppressing fatty acid β-oxidation.
- Identified a novel cholesterol-OGT-PPARα axis where cholesterol suppresses O-GlcNAcylation, inhibiting PPARα activity and fatty acid oxidation.
- Demonstrated that restoring O-GlcNAcylation or activating PPARα alleviated steatosis in mice.
Conclusions:
- Uncovered a new molecular pathway (cholesterol-OGT-PPARα) driving hepatic steatosis through suppressed fatty acid oxidation.
- Targeting O-GlcNAc cycling or PPARα activation offers potential therapeutic strategies for MASLD.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...